A new paper by Dana-Farber Cancer Institute scientists lays the foundation for targeted therapies to inhibit activation of nuclear factor kappa B (NF-κB), a transcription factor that plays a role in various autoimmune and inflammatory diseases and cancers.
Research Reveals Drug Target for Disease-Linked NF-κB Activation miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
New Strategy Improves Treatment by Targeting Lung Cancer Memories miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Robert "Bob" Loughlin - Jamestown Press jamestownpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamestownpress.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Dewpoint Therapeutics, Inc. today announced biomolecular scientist Anthony Hyman, head of the Max Planck Institute of Molecular Cell Biology.